Pages that link to "Item:Q3164275"
Jump to navigation
Jump to search
The following pages link to (Q3164275):
Displayed 8 items.
- ALASCA — VALIDATION OF NEW THERAPEUTIC TARGETS AND SUBSEQUENT DEVELOPMENT OF POTENTIAL DRUG CANDIDATES FOR NEUROLOGICAL DISORDERS (Q3164276) (← links)
- INOA — APPLIED RESEARCH FOR THE VALIDATION OF AN INNOVATIVE THERAPEUTIC APPROACH TO ALZHEIMER’S DISEASE AND DISCOVERY OF POTENTIAL NEW DRUGS (Q3165073) (← links)
- DISCOVERY OF MOLECULES WITH INHIBITORY ACTIVITY THAT CAN SERVE AS A STARTING POINT FOR OBTAINING DRUGS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES (Q3169294) (← links)
- APPLIED RESEARCH FOR VALIDATION OF AN INNOVATIVE THERAPEUTIC APPROACH TO ALZHEIMER’S DISEASE AND DISCOVERY OF POTENTIAL NEW DRUGS (Q3170528) (← links)
- CONDUCTING RESEARCH TO OBTAIN MOLECULES THAT ALLOW ACTION ON ONCOLOGICAL AND CENTRAL NERVOUS SYSTEM DISEASES BY MODULATING IMMUNE MECHANISMS FOR INDUCING INFLAMMATION (Q3176058) (← links)
- DEVELOPMENT OF NEW MOLECULES FOR THE CREATION OF ACTIVE DRUGS AGAINST INFLUENZA TYPE A AND B (Q3176060) (← links)
- DISCOVERY OF MOLECULES THAT CAN SERVE AS A STARTING POINT FOR OBTAINING DRUGS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NEUROPLASTICITY DEFICITS (Q3178965) (← links)
- DEVELOPMENT OF NEW MOLECULES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS), SUCH AS DEPRESSION, SCHIZOPHRENIA, PARKINSON’S DISEASE AND CHRONIC PAIN. (Q3180319) (← links)